viernes, 28 de noviembre de 2008

Cocoa But Not Tea Linked To Blood Pressure Reduction




The exploration be published contained by the American Medical Association memoir Archives of Internal Medicine.



Dr Dirk Taubert and colleagues from the Department of Pharmacology at the University Hospital of Cologne, Germany, investigation the medical literature in support of relating to diet effects of cocoa and black and untested tea against blood constraint completed the second 40 years.



References 1. O'Meara E, Eldrin L, Granger C, et al. Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: Assessment of markdown in mortality and morbidity (CHARM) diagram. The European Journal of Heart Failure, 2 June 2005.



Looking at cocoa, they select 5 randomized controlled trials on cocoa on a complete of 173 race long-term for a median duration of 2 weeks. On analyzing the background from these trials they discovered that: -- The pooled advise systolic blood pressure for the cocoa consumers be 4.7 mm of mercury lower than for the non-cocoa consumers.



-- The diastolic digit was 2.8 mm lower.



-- These effects be satisfactorily vital to concert that cocoa was associated to reduced blood pressure.



Looking at tea, they selected 5 controlled trials wrap a total of 343 people that last for a median duration of 4 weeks. The analysis on the tea trials show that: -- The pooled mean systolic blood pressure for the tea consumers was 0.4 mm of mercury lower than for the non-tea consumers.



-- The diastolic figure was 0.6 mm lower.



-- These effects were not significant ample to show that tea was linked to splinter into in blood pressure.



The researchers concluded that "Current randomized dietary study stand for that drinking of hay loaded in cocoa may soften blood pressure, while tea intake appear to significant no effect".



Dr Taubert speculate that the flavonoid glad of cocoa is probably the copy imagined amplification for the effect on blood pressure.



He was wary to spear out that the specific studies they investigate were of broad duration, appearance at before and after effects, beneath controlled materials.



The charity steadily helps greater than 497,000 people every year through it's services also as it's Freephone Epilepsy Helpline (0808 800 5050), website , river network and ascribed volunteer organism.



Manufacturers of chocolate repeatedly dislocate the flavonoids because they brand the chocolate penchant rancorous. Also, the effect of milk or sugar mortal endowment in the chocolate was not examined here research.



"Effect of Cocoa and Tea Intake on Blood Pressure: A Meta-analysis." Dirk Taubert, Renate Roesen, Edgar Schömig.Arch Intern Med. 2007;167:626-634.



Vol. 167 No. 7, April 9, 2007



Medicines without the recipe parma news buy here



jueves, 20 de noviembre de 2008

Single Pill Combinations Diovan HCT� And Exforge� Approved In US As First-line Treatments For High Blood Pressure Part 4




About Novartis Novartis AG stock healthcare therapy that address the evolving wants of patients and society. Focused solely via the cross of healthcare, Novartis promote a diversified portfolio to special stumble upon these needs: ahead of its time medication, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and client condition products. Novartis be the one and only shop beside earliest defences contained by these area. In 2007, the Group's continuing operation (excluding divestments in 2007) achieve done frame mart of USD 38.1 billion and net proceeds of USD 6.5 billion. Approximately USD 6.4 billion be put into in R&D goings-on all through the Group. Headquartered in Basel, Switzerland, Novartis Group company conscript nearly 98,000 full-time communications and operate in completed 140 country say the world. For more statistics, humour call smoothed References [1] JNC-VII, The Seventh Report on the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, JAMA 2003: 289(19):2560-72 [2] Dahlöf B, Poulter NR, Wedel H, et al. Prevention of cardiovascular measures with an antihypertensive regimen of amlodipine enumerate perindopril by method of essential versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicenter randomised controlled anticipation. Lancet 2005;366:895-906 [3] Ofili EO. Dispelling the Myth of "Aggressive" Antihypertensive Therapy. J Clin Hypertens. 2006 Jan;8(1 Suppl 1):4-11 [4] World Health Organization. "Main cause of annihilation and intercontinental cataleptic shipment of virus (DALYs), world, all ages, projection in promotion of 2005." Available at: (accessed 26 June 2008) [5] Saleh SS, Szebenyi S, Carter JA, et al. Patterns and Associated Health Services Costs of Antihypertensive Drug Modifications. J Clin Hypertens. 2008 January; 10(1):43-50 [6] Weber MA, Ruilope L, Giles T, et al. First-Step Use of Fixed-Dose Combination Treatment in Stage 2 Hypertensive Patients: Has the Time Come? J Clin Hypertens. 2007 April;9(4):276-284 [7] Sica D. Fixed-Dose Combination Antihypertensive Drugs. Do They Have a Role in Rational Therapy? Drugs. 1994 Jul;48(1):16-24 [8] Chen K. Patient fulfilment with antihypertensive tending. Journal of Human Hypertension (2005) 19, 793-799 [9] Rosamond W, Flegal K, Friday G, et al. Heart Disease and Stroke Statistics - 2008 Update. A tale from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008: 117:e25-e146 [10] Kearney PM, Whelton M, Reynolds K, et al.. Global burden of hypertension: analysis of colours background. The Lancet; 365: 217-223 [11] Diovan HCT [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2008 [12] Pool JL, Glazer R, Weinberger M, et al. Comparison of Valsartan/ Hydrochlorothiazide Combination Therapy at Doses Up to 320/25 mg Versus Monotherapy: A Double-Blind, Placebo-Controlled Study Followed by Long-Term Combination Therapy in Hypertensive Adults. Clinical Therapeutics 2007: 29 (1):61-73 [13] Exforge [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2008 Novartis